Aegis Therapeutics LLC is a drug delivery technology company commercializing its patented or proprietary drug delivery and drug formulation technologies through product specific licenses. The Intravail® drug delivery technology enables the non-invasive delivery of a broad range of protein, peptide and non-peptide macromolecular therapeutics that can currently only be administered by injection. ProTek® technology is applicable to injectable, intranasal, and other dosage forms of peptide or protein therapeutics.